Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | DGKA | P23743 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27710759 | 0.94 | USP2 (0.66) | USP2LMNAKDM4EDUSP3MEN1 | |
| SCHEMBL113021 | 0.92 | USP2 (0.69) | USP2LMNAKDM4EDUSP3MEN1 | |
| SCHEMBL20743365 | 0.92 | USP2 (0.69) | USP2LMNAKDM4EDUSP3MEN1 | |
| SCHEMBL28115449 | 0.92 | USP2 (0.69) | USP2LMNAKDM4EDUSP3MEN1 | |
| SCHEMBL14714348 | 0.92 | USP2 (0.69) | USP2LMNAKDM4EDUSP3MEN1 | |
| SCHEMBL344684 | 0.92 | USP2 (0.69) | USP2LMNAKDM4EDUSP3MEN1 | |
| SCHEMBL26496284 | 0.92 | USP2 (0.69) | USP2LMNAKDM4EDUSP3MEN1 | |
| SCHEMBL1752698 | 0.92 | USP2 (0.69) | USP2LMNAKDM4EDUSP3MEN1 | |
| SCHEMBL93726 | 0.92 | USP2 (0.69) | USP2LMNAKDM4EDUSP3MEN1 | |
| SCHEMBL6015046 | 0.89 | USP2 (0.42) | USP2LMNAKDM4EDUSP3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3494104-B1 | WARMING SENSATION COMPOUNDS | TAKASAGO PERFUMERY CO LTD (JP) | 2023-11-15 | — | — | EP | claimed |
| CN-109803948-B | Warming sensation compound | 高砂香料工业株式会社 | 2022-03-01 | — | — | CN | claimed |
| EP-2810564-B1 | Sensation masking composition | TAKASAGO INT CORP (USA) (US) | 2017-06-14 | — | — | EP | claimed |
| EP-1639072-A1 | SOLVENT TREATMENT OF FABRIC ARTICLES | The Procter & Gamble Company (US) | 2006-03-29 | — | — | EP | claimed |
| US-20050223500-A1 | Solvent treatment of fabric articles | THE PROCTER & GAMBLE COMPANY | 2005-10-13 | — | — | US | claimed |
| WO-2005003278-A1 | SOLVENT TREATMENT OF FABRIC ARTICLES | THE PROCTER & GAMBLE COMPANY (US) | 2005-01-13 | — | — | WO | claimed |
| US-20260034046-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING CATIONIC SURFACTANT AND FATTY ALCOHOL | L'OREAL (FR) | 2026-02-05 | — | — | US | disclosed |
| US-20260000602-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION | L'OREAL (FR) | 2026-01-01 | — | — | US | disclosed |
| EP-3494104-B1 | WARMING SENSATION COMPOUNDS | TAKASAGO PERFUMERY CO LTD (JP) | 2023-11-15 | — | — | EP | disclosed |
| EP-3510010-B1 | TASTE MODULATING ALDEHYDE | TAKASAGO PERFUMERY CO LTD (JP) | 2023-09-06 | — | — | EP | disclosed |
| US-11540542-B2 | Taste modulating aldehydes | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2023-01-03 | — | — | US | disclosed |
| CN-109996778-B | Taste modifying aldehydes | 高砂香料工业株式会社 | 2022-12-13 | — | — | CN | disclosed |
| EP-3984599-A1 | ENHANCED PERFUME COMPOSITIONS | Takasago International Corporation (JP) | 2022-04-20 | — | — | EP | disclosed |
| US-20090208427-A1 | Vanillin Acetals and Sensory Stimulant Composition Containing the Same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-08-20 | — | — | US | disclosed |
| CN-101218222-A | Vanillin acetals and sensory stimulant composition containing the same | TAKASAGO PERFUMERY CO LTD (JP) | 2008-07-09 | — | — | CN | disclosed |
| EP-1902043-A1 | VANILLIN ACETALS AND SENSORY STIMULANT COMPOSITION CONTAINING THE SAME | Takasago International Corporation (JP) | 2008-03-26 | — | — | EP | disclosed |
| WO-2007004740-A1 | VANILLIN ACETALS AND SENSORY STIMULANT COMPOSITION CONTAINING THE SAME | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-01-11 | — | — | WO | disclosed |
| US-20060269500-A1 | Topical warming composition | TAKASAGO INTERNATIONAL CORP. (USA) (US) | 2006-11-30 | — | — | US | disclosed |
| CN-85108027-A | Spray and Emulsion that oral fine looses | — | 1986-07-16 | — | — | CN | disclosed |
| EP-0180483-A2 | Oral fine dispersions sprays and emulsions | ADVANCED ORAL HEALTHCORP LIMITED (CA) | 1986-05-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11540542-B2 | Taste modulating aldehydes | TAS2R10, TAS2R50, TAS2R1 | USP2 4146/4885LMNA 4718/4885KDM4E 2218/4885 |
| US-20060269500-A1 | Topical warming composition | CUTA, NACA, LSM14A | USP2 4194/4885LMNA 1435/4885KDM4E 2963/4885 |
| US-20260000602-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION | TAS2R40, BRDT, APOB | USP2 4212/4885LMNA 1502/4885KDM4E 2035/4885 |
| US-20260034046-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING CATIONIC SURFACTANT AND FATTY ALCOHOL | KRT18, DSG1, PRKDC | USP2 4278/4885LMNA 586/4885KDM4E 767/4885 |
| US-20090208427-A1 | Vanillin Acetals and Sensory Stimulant Composition Containing the Same | TRPA1, TRPV1, TAS2R5 | USP2 1643/4885LMNA 3990/4885KDM4E 1157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.